Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abnormal back muscle activity in cervical dystonia
2024-517068-43-00Phase 4Completed
- Sponsor
- Pirkanmaan hyvinvointialue
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Pirkanmaan hyvinvointialue. Primary endpoint: Change in dystonia severity by Unified Dystonia Rating Scale (UDRS). Started Aug 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2024-517068-43-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517068-43-00.